BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 22548505)

  • 21. Development and evaluation of an integrated liver nodule diagnostic method by combining the liver segment division and lesion localization/classification models for enhanced focal liver lesion detection.
    Takenaga T; Hanaoka S; Nomura Y; Nakao T; Shibata H; Miki S; Yoshikawa T; Hayashi N; Abe O
    Radiol Phys Technol; 2024 Mar; 17(1):103-111. PubMed ID: 37917288
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gadoxetic acid (Primovist®) beyond the characterization of hepatic lesions in MRI: the case of biliary leaks.
    Salgado-Parente A; Gil-Boronat A; Canales Lachen E; Muñoz Beltrán M
    Rev Esp Enferm Dig; 2023 Aug; 115(8):459-460. PubMed ID: 36263828
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Imaging Characteristics and Pathological Analysis of Primary Hepatic Neuroendocrine Neoplasms.
    Li D; He Y; Xie G; Mao Z; Liu P
    Curr Med Imaging; 2023 Nov; ():. PubMed ID: 37936444
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gadolinium-free Magnetic Resonance Imaging of the Liver via an Oatp1-Targeted Manganese(III) Porphyrin.
    Nyström NN; Liu H; Martinez FM; Zhang XA; Scholl TJ; Ronald JA
    J Med Chem; 2022 Jul; ():. PubMed ID: 35852350
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Liver function and image evaluation after radiotherapy for liver metastases after resection of sigmoid colon cancer a case report.
    Ito F; Kawai Y; Nakamura M; Toyama H; Hayashi S
    Int J Surg Case Rep; 2024 Mar; 116():109302. PubMed ID: 38335914
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Primary hepatic undiferentiated pleomorphic sarcoma co-existed with hepatocellular carcinoma.
    Qu J; Cao Q; Zhang M; Liu Y; Li J
    Rev Esp Enferm Dig; 2023 Oct; ():. PubMed ID: 37882154
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Computed tomography may detect liver infiltration of canine diffuse hepatic lymphoma.
    Tanaka T; Yamazaki H; Ashida K; Iimori Y; Mie K; Nishida H; Akiyoshi H
    Vet Med Sci; 2021 Nov; 7(6):2172-2177. PubMed ID: 34390546
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Retracted: Evaluation of Rabbits Liver Fibrosis Using Gd-DTPA-BMA of Dynamic Contrast-Enhanced Magnetic Resonance Imaging.
    And Alternative Medicine EC
    Evid Based Complement Alternat Med; 2023; 2023():9816867. PubMed ID: 37388113
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quantification of Liver Function with MRI: Is It Ready?
    Reeder SB
    Radiology; 2019 Jan; 290(1):134-135. PubMed ID: 30375935
    [No Abstract]   [Full Text] [Related]  

  • 30. Comparative Oncology: Management of Hepatic Neoplasia in Humans and Dogs.
    Gibson EA; Goldman RE; Culp WTN
    Vet Sci; 2022 Sep; 9(9):. PubMed ID: 36136704
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessment of hepatitis and fibrosis using Gd-EOB-DTPA MRI in dogs.
    Tanaka T; Nishida H; Mie K; Yamazaki H; Lin LS; Akiyoshi H
    Vet Rec Open; 2020; 7(1):e000371. PubMed ID: 32818058
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Magnetic resonance imaging of liver tumors using gadoxetic acid (Gd-EOB-DTPA) - pilot study.
    Borusewicz P; Stańczyk E; Kubiak K; Spużak J; Glińska-Suchocka K; Jankowski M; Sławuta P; Kubiak-Nowak D; Podgórski P
    BMC Vet Res; 2019 Aug; 15(1):293. PubMed ID: 31412920
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Primovist, Eovist: what to expect?
    Van Beers BE; Pastor CM; Hussain HK
    J Hepatol; 2012 Aug; 57(2):421-9. PubMed ID: 22504332
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Liver vessel enhancement by Gd-BOPTA and Gd-EOB-DTPA: a comparison in healthy volunteers.
    Brismar TB; Dahlstrom N; Edsborg N; Persson A; Smedby O; Albiin N
    Acta Radiol; 2009 Sep; 50(7):709-15. PubMed ID: 19701821
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Contrast enhanced liver MRI in patients with primary sclerosing cholangitis: inverse appearance of focal confluent fibrosis on delayed phase MR images with hepatocyte specific versus extracellular gadolinium based contrast agents.
    Husarik DB; Gupta RT; Ringe KI; Boll DT; Merkle EM
    Acad Radiol; 2011 Dec; 18(12):1549-54. PubMed ID: 21958599
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Liver tumors: comparison of MR imaging with Gd-EOB-DTPA and Gd-DTPA.
    Vogl TJ; Kümmel S; Hammerstingl R; Schellenbeck M; Schumacher G; Balzer T; Schwarz W; Müller PK; Bechstein WO; Mack MG; Söllner O; Felix R
    Radiology; 1996 Jul; 200(1):59-67. PubMed ID: 8657946
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Liver. III: Gadolinium-based hepatobiliary contrast agents (Gd-EOB-DTPA and Gd-BOPTA/Dimeg).
    Giovagnoni A; Paci E
    Magn Reson Imaging Clin N Am; 1996 Feb; 4(1):61-72. PubMed ID: 8673717
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Contrast agent Gd-EOB-DTPA (EOB·Primovist®) for low-field magnetic resonance imaging of canine focal liver lesions.
    Yonetomi D; Kadosawa T; Miyoshi K; Nakao Y; Homma E; Hanazono K; Yamada E; Nakamura K; Ijiri A; Minegishi N; Maetani S; Hirayama K; Taniyama H; Nakade T
    Vet Radiol Ultrasound; 2012; 53(4):371-80. PubMed ID: 22548505
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.